anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

208,741-208,800 of 319,975

filter-aware
47
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Loop · Mece Breakdown1 hit
48
The slide uses a grid layout to associate each executive with a column of professional logos.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Loop · Mece Breakdown1 hit
49
The slide uses a grid layout to associate each leader with a column of logos representing their past experience.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Loop · Mece Breakdown1 hit
50
The slide uses a Gantt-style chart to show the progress of various drug candidates through clinical development stages.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Loop · Mece Breakdown1 hit
51
The slide uses a before-after visual comparison of brain connectivity to illustrate the mechanism of action.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
52
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
53
The chart displays STAI-G scores over 24 weeks, highlighting a statistically significant divergence between the LSD and placebo groups.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
54
The chart shows a clear dose-response relationship with high dose performing significantly better than low dose.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
55
The slide uses a timeline-based study design diagram to illustrate the randomization and follow-up periods.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
56
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
57
The slide uses a chronological process flow to describe the patient experience.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
58
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
59
The slide uses a process-oriented layout to define the commercialization strategy.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
60
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
61
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
01
Slide 1
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
02
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
03
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
04
The slide uses a grid layout to associate each executive with their past/current professional affiliations.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
05
The slide highlights the depth of experience by listing previous company affiliations for each leader.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
06
Uses a pictogram (4/5 dark blue) to visually represent the '1 in 5' statistic.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a matrix structure to categorize drug development strategy by generation (Classic, 2nd Gen/Optimized, 3rd Gen/NCEs).MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a Gantt-style chart to show the progress of different drug candidates through clinical development stages.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a flywheel diagram to represent the R&D strategy and a bar chart to demonstrate the impact of IP strategies on market protection duration.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
Uses a brain diagram to map specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Uses a brain scan visualization to illustrate the impact of a serotonin agonist.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · Market Size1 hit
13
The slide uses a table to establish historical credibility for the company's therapeutic approach.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
14
Data source: Holze, Gasser et al. 2022. Biological Psychiatry.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
15
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
16
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
17
The slide uses a timeline diagram to illustrate the study flow from randomization to follow-up.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide uses a process-oriented layout to describe the commercialization strategy.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
19
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Loop · Why Now1 hit
20
The slide uses a bar chart to bridge the gap between patient needs and the proposed solution's potential impact.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · Competition1 hit
21
The chart demonstrates the therapeutic index advantage of the R-enantiomer.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
22
The chart shows a comparison between Placebo and MDMA at 1 month and 6 months, indicating sustained improvement.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
23
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
24
The slide uses a line chart metaphor to show patient stability over time, highlighting the 'gap' filled by MM-110.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
25
The slide uses two distinct chart types (bar and line) to show efficacy across different translational markers.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
26
The slide uses a clear, bulleted list to summarize clinical trial outcomes.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
27
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
28
The slide uses a three-column layout to map partners/capabilities to specific R&D stages.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
29
The slide highlights a strategic partnership and lists specific research programs (LSD, MDMA, Mescaline, DMT) and their strategic benefits.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
30
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
31
The slide uses a timeline-based framework to map specific digital solutions to different stages of drug development.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
32
The slide uses a linear process flow mapped to specific digital product features.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
33
The central diagram is a hub-and-spoke model showing stakeholder alignment.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
34
The slide uses a matrix-like layout to show product status across development phases.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · Financials1 hit
35
MindMed | Investor Presentation Deck | 36 slidesMindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
36
This appears to be a closing slide or a section divider given the page number 36.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
01
Slide 1
Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slidesNano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Problem1 hit
02
Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slidesNano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Problem1 hit
03
Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slidesNano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Problem1 hit
04
Uses a top-down hierarchy to frame the Nano offer as the 'superior' choice against two 'inferior' alternatives.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Loop · Analogy1 hit
05
Uses a three-column layout to frame the subject company (Nano) as the superior choice against two competitors.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Loop · Analogy1 hit
06
The slide uses a combination of a line chart for share price and a bar chart for cumulative cash burn to illustrate value destruction.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
07
The slide uses a contrast-based layout to highlight performance failures.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
08
Uses a 'villain_critique' approach to frame the target company as a value-destroying entity.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Agitate1 hit
09
The slide uses a combination of a stacked bar chart for analyst ratings and a line chart for share price performance to illustrate the 'villain's' (3D Systems) poor track record.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Agitate1 hit